errata Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

被引：0
作者：
Maria Pilla
Sylvie Perachon
François Sautel
Fabrice Garrido
André Mann
Camille G. Wermuth
Jean-Charles Schwartz
Barry J. Everitt
Pierre Sokoloff
机构：
来源：
Nature | 1999年 / 401卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 403
相关论文
共 50 条
[31]   (±)VK4-40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents [J].
Jordan, Chloe J. ;
He, Yi ;
Bi, Guo-Hua ;
You, Zhi-Bing ;
Cao, Jianjing ;
Xi, Zheng-Xiong ;
Newman, Amy Hauck .
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (20) :4796-4807
[32]   Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans [J].
Newton, Thomas F. ;
Haile, Colin N. ;
Mahoney, James J., III ;
Shah, Ravi ;
Verrico, Christopher D. ;
De La Garza, Richard, II ;
Kosten, Thomas R. .
PSYCHIATRY RESEARCH, 2015, 230 (01) :44-49
[33]   Functionally Selective Dopamine D2, D3 Receptor Partial Agonists [J].
Moeller, Dorothee ;
Kling, Ralf C. ;
Skultety, Marika ;
Leuner, Kristina ;
Huebner, Harald ;
Gmeiner, Peter .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) :4861-4875
[34]   Systemic Exposure to the HIV Protein gp120 Prevents the Inhibition of Cue-Induced Cocaine Seeking by the Novel Dopamine D3 Receptor Partial Agonist MC-25-41 [J].
Namba, Mark ;
Phillips, Megan N. ;
Chen, Peng-Jen ;
Blass, Benjamin E. ;
Olive, M. Foster ;
Neisewander, Janet L. .
NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) :485-486
[35]   Dopamine D3 receptor ligands attenuated the cue-induced reinstatement of cocaine-seeking in rats without influencing the same response for natural rewards [J].
Gál, K ;
Gyertyán, I .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 :S315-S315
[36]   Cocaine-Seeking Behavior in Response to Drug-Associated Stimuli in Rats: Involvement of D3 and D2 Dopamine Receptors [J].
L Cervo ;
F Carnovali ;
J A Stark ;
T Mennini .
Neuropsychopharmacology, 2003, 28 :1150-1159
[37]   Cariprazine, a selective dopamine D3 receptor partial agonist with unique features to treat schizophrenia negative and cognitive symptoms [J].
Laszlovszky, I. ;
Barabassy, A. ;
Kiss, B. ;
Szatmari, B. ;
Adham, N. ;
Earley, W. ;
Nemeth, G. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 :S398-S399
[38]   Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys [J].
Woodlief, Kendall ;
Allen, Mia I. ;
Cornelissen, Jeremy C. ;
Banks, Matthew L. ;
Newman, Amy Hauck ;
Nader, Michael A. .
NEUROPSYCHOPHARMACOLOGY, 2023, 48 (12) :1716-1723
[39]   Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys [J].
Kendall Woodlief ;
Mia I. Allen ;
Jeremy C. Cornelissen ;
Matthew L. Banks ;
Amy Hauck Newman ;
Michael A. Nader .
Neuropsychopharmacology, 2023, 48 :1716-1723
[40]   Identification of a Novel, Highly Potent D3 Dopamine Receptor-selective Agonist [J].
Sibley, David ;
Moritz, Amy ;
Free, R. Benjamin ;
Conroy, Jennie ;
Weiner, Warren ;
Barnaeva, Elena ;
Southall, Noel ;
Ferrer, Marc ;
Javitch, Jonathan ;
Aube, Jeffrey ;
Frankowski, Kevin .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 :S287-S288
12345